559 related articles for article (PubMed ID: 33729551)
1. Classification of high-grade cervical intraepithelial neoplasia by p16
Vink FJ; Dick S; Heideman DAM; De Strooper LMA; Steenbergen RDM; Lissenberg-Witte BI; ; Floore A; Bonde JH; Oštrbenk Valenčak A; Poljak M; Petry KU; Hillemanns P; van Trommel NE; Berkhof J; Bleeker MCG; Meijer CJLM
Int J Cancer; 2021 Aug; 149(3):707-716. PubMed ID: 33729551
[TBL] [Abstract][Full Text] [Related]
2. FAM19A4/miR124-2 Methylation Testing and Human Papillomavirus (HPV) 16/18 Genotyping in HPV-Positive Women Under the Age of 30 Years.
Vink FJ; Meijer CJLM; Hesselink AT; Floore AN; Lissenberg-Witte BI; Bonde JH; Pedersen H; Cuschieri K; Bhatia R; Poljak M; Oštrbenk Valenčak A; Hillemanns P; Quint WGV; Del Pino M; Kenter GG; Steenbergen RDM; Heideman DAM; Bleeker MCG
Clin Infect Dis; 2023 Feb; 76(3):e827-e834. PubMed ID: 35686306
[TBL] [Abstract][Full Text] [Related]
3. Characterization of cervical biopsies of women with HIV and HPV co-infection using p16
Kremer WW; Vink FJ; van Zummeren M; Dreyer G; Rozendaal L; Doorbar J; Bleeker MCG; Meijer CJLM
Mod Pathol; 2020 Oct; 33(10):1968-1978. PubMed ID: 32249820
[TBL] [Abstract][Full Text] [Related]
4. Expression of p16 and HPV E4 on biopsy samples and methylation of FAM19A4 and miR124-2 on cervical cytology samples in the classification of cervical squamous intraepithelial lesions.
Leeman A; Jenkins D; Del Pino M; Ordi J; Torné A; Doorbar J; Meijer CJLM; van Kemenade FJ; Quint WGV
Cancer Med; 2020 Apr; 9(7):2454-2461. PubMed ID: 32022461
[TBL] [Abstract][Full Text] [Related]
5. HPV E4 expression and DNA hypermethylation of CADM1, MAL, and miR124-2 genes in cervical cancer and precursor lesions.
Zummeren MV; Kremer WW; Leeman A; Bleeker MCG; Jenkins D; Sandt MV; Doorbar J; Heideman DAM; Steenbergen RDM; Snijders PJF; Kenter GG; Quint WGV; Berkhof J; Meijer CJLM
Mod Pathol; 2018 Dec; 31(12):1842-1850. PubMed ID: 30135508
[TBL] [Abstract][Full Text] [Related]
6. p16INK4A immunohistochemical staining and predictive value for progression of cervical intraepithelial neoplasia grade 1: a prospective study in China.
Liao GD; Sellors JW; Sun HK; Zhang X; Bao YP; Jeronimo J; Chen W; Zhao FH; Song Y; Cao Z; Zhang SK; Xi MR; Qiao YL
Int J Cancer; 2014 Apr; 134(7):1715-24. PubMed ID: 24105727
[TBL] [Abstract][Full Text] [Related]
7. Immunostaining of p16(INK4a)/Ki-67 and L1 capsid protein on liquid-based cytology specimens obtained from ASC-H and LSIL-H cases.
Byun SW; Lee A; Kim S; Choi YJ; Lee YS; Park JS
Int J Med Sci; 2013; 10(12):1602-7. PubMed ID: 24151431
[TBL] [Abstract][Full Text] [Related]
8. Stratification of HPV-induced cervical pathology using the virally encoded molecular marker E4 in combination with p16 or MCM.
Griffin H; Soneji Y; Van Baars R; Arora R; Jenkins D; van de Sandt M; Wu Z; Quint W; Jach R; Okon K; Huras H; Singer A; Doorbar J
Mod Pathol; 2015 Jul; 28(7):977-93. PubMed ID: 25953390
[TBL] [Abstract][Full Text] [Related]
9. Clinical Regression of High-Grade Cervical Intraepithelial Neoplasia Is Associated With Absence of
Kremer WW; Dick S; Heideman DAM; Steenbergen RDM; Bleeker MCG; Verhoeve HR; van Baal WM; van Trommel N; Kenter GG; Meijer CJLM; Berkhof J
J Clin Oncol; 2022 Sep; 40(26):3037-3046. PubMed ID: 35512257
[TBL] [Abstract][Full Text] [Related]
10. Defining hrHPV genotypes in cervical intraepithelial neoplasia by laser capture microdissection supports reflex triage of self-samples using HPV16/18 and FAM19A4/miR124-2 methylation.
Leeman A; Ebisch RMF; Kasius A; Bosgraaf RP; Jenkins D; van de Sandt MM; de Strooper LMA; Heideman DAM; Snijders PJF; Massuger LFAG; Bekkers RLM; Meijer CJLM; van Kemenade FJ; Quint WGV; Melchers WJG
Gynecol Oncol; 2018 Nov; 151(2):311-318. PubMed ID: 30219239
[TBL] [Abstract][Full Text] [Related]
11. Exposure to tobacco smoke measured by urinary nicotine metabolites increases risk of p16/Ki-67 co-expression and high-grade cervical neoplasia in HPV positive women: A two year prospective study.
White CM; Bakhiet S; Bates M; Ruttle C; Pilkington LJ; Keegan H; O'Toole SA; Sharp L; O'Kelly R; Tewari P; Flannelly G; Martin CM; O'Leary JJ;
Cancer Epidemiol; 2020 Oct; 68():101793. PubMed ID: 32841926
[TBL] [Abstract][Full Text] [Related]
12. FAM19A4/miR124-2 methylation analysis as a triage test for HPV-positive women: cross-sectional and longitudinal data from a Dutch screening cohort.
Vink FJ; Lissenberg-Witte BI; Meijer CJLM; Berkhof J; van Kemenade FJ; Siebers AG; Steenbergen RDM; Bleeker MCG; Heideman DAM
Clin Microbiol Infect; 2021 Jan; 27(1):125.e1-125.e6. PubMed ID: 32222459
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of p16, human papillomavirus capsid protein L1 and Ki-67 in cervical intraepithelial lesions: potential utility in diagnosis and prognosis.
Alshenawy HA
Pathol Res Pract; 2014 Dec; 210(12):916-21. PubMed ID: 25149503
[TBL] [Abstract][Full Text] [Related]
14. Long-term CIN3+ risk of HPV positive women after triage with FAM19A4/miR124-2 methylation analysis.
Dick S; Kremer WW; De Strooper LMA; Lissenberg-Witte BI; Steenbergen RDM; Meijer CJLM; Berkhof J; Heideman DAM
Gynecol Oncol; 2019 Aug; 154(2):368-373. PubMed ID: 31182225
[TBL] [Abstract][Full Text] [Related]
15. [Evaluation of p16INK4a and Ki-67 proteins expression in cervical intraepithelial neoplasia and their correlation with HPV-HR infection].
Ungureanu C; Teleman S; Socolov D; Anton G; Mihailovici MS
Rev Med Chir Soc Med Nat Iasi; 2010; 114(3):823-8. PubMed ID: 21243810
[TBL] [Abstract][Full Text] [Related]
16. Performance of HPV E4 and p16
Damgaard RK; Jenkins D; de Koning MN; Quint WG; Stoler MH; Doorbar J; Kahlert J; Gravitt PE; Steiniche T; Petersen LK; Hammer A
BMJ Open; 2022 Jul; 12(7):e059593. PubMed ID: 35793925
[TBL] [Abstract][Full Text] [Related]
17. Three-tiered score for Ki-67 and p16
van Zummeren M; Leeman A; Kremer WW; Bleeker MCG; Jenkins D; van de Sandt M; Heideman DAM; Steenbergen R; Snijders PJF; Quint WGV; Berkhof J; Meijer CJLM
J Clin Pathol; 2018 Nov; 71(11):981-988. PubMed ID: 30012698
[TBL] [Abstract][Full Text] [Related]
18. Triage of LSIL/ASC-US with p16/Ki-67 dual staining and human papillomavirus testing: a 2-year prospective study.
White C; Bakhiet S; Bates M; Keegan H; Pilkington L; Ruttle C; Sharp L; O' Toole S; Fitzpatrick M; Flannelly G; O' Leary JJ; Martin CM
Cytopathology; 2016 Aug; 27(4):269-76. PubMed ID: 26932360
[TBL] [Abstract][Full Text] [Related]
19. Human papillomavirus DNA, HPV L1 capsid protein and p16
Hu H; Zhao J; Yu W; Zhao J; Wang Z; Jin L; Yu Y; Han L; Wang L; Zhu H; Li F
Arch Gynecol Obstet; 2019 Jan; 299(1):141-149. PubMed ID: 30390110
[TBL] [Abstract][Full Text] [Related]
20. Methylation markers FAM19A4 and miR124-2 as triage strategy for primary human papillomavirus screen positive women: A large European multicenter study.
Bonde J; Floore A; Ejegod D; Vink FJ; Hesselink A; van de Ven PM; Valenčak AO; Pedersen H; Doorn S; Quint WG; Petry KU; Poljak M; Stanczuk G; Cuschieri K; de Sanjosé S; Bleeker M; Berkhof J; Meijer CJLM; Heideman DAM
Int J Cancer; 2021 Jan; 148(2):396-405. PubMed ID: 32997803
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]